US STOCKS-Dow leads gains on Wall Street as investors await rate clues

Reuters03-28

* Merck up after US FDA approves therapy for rare lung condition * Trump's media firm extends gains after stellar debut * GameStop faces 'unsustainable' sales decline, shares slide * ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2422879940?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-03-28 02:58","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2422879940","market":"us","top_or_hot":-1,"title":"US STOCKS-Dow leads gains on Wall Street as investors await rate clues","media":"Reuters","content":"<div>\n<p>* \n Merck up after US FDA approves therapy for rare lung condition \n * \n Trump's media firm extends gains after stellar debut \n * \n GameStop faces 'unsustainable' sales decline, shares slide \n * \n ...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-dow-leads-gains-185817574.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US STOCKS-Dow leads gains on Wall Street as investors await rate clues</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS STOCKS-Dow leads gains on Wall Street as investors await rate clues\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-28 02:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-stocks-dow-leads-gains-185817574.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>* \n Merck up after US FDA approves therapy for rare lung condition \n * \n Trump's media firm extends gains after stellar debut \n * \n GameStop faces 'unsustainable' sales decline, shares slide \n * \n ...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-dow-leads-gains-185817574.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"QQQ","symbol_name":"纳指100ETF","start_time":0,"source_url":"https://finance.yahoo.com/news/us-stocks-dow-leads-gains-185817574.html","article_id":"2422879940","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2422879940","pubTimestamp":1711565897,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Merck up after US FDA approves therapy for rare lung condition. Trump's media firm extends gains after stellar debut. NEW YORK, March 27  - The Dow was the best performing of the three major indexes on Wednesday, paced by gains in drugmaker Merck, while as investors looked towards the next piece of inflation data and Federal Reserve policymaker commentary for insight on the rate path.Merck & Co advanced 4.77% as the biggest boost and percentage gained on the Dow after the U.S. Food and Drug Administration approved its therapy for adults suffering from a rare lung condition.The blue-chip Dow sits roughly 1% away from breaking the 40,000 level for the first time.Recent data that showed hotter than expected inflation in the form of consumer prices  and producer prices  failed to markedly disrupt market expectations for a rate cut of at least 25 basis points  from the Federal Reserve in June.The Fed kept its projections for three rate cuts this year intact at its policy meeting last week, ","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"QQQ":"纳指100ETF","QLD":"纳指两倍做多ETF","PPI":"AXS Astoria Inflation Sensitive ETF","PSQ":"纳指反向ETF","SG9999001176.USD":"United Global Healthcare Acc USD","SSO":"两倍做多标普500ETF","IVV":"标普500指数ETF","MRK":"默沙东","COMP":"Compass, Inc.","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","SQQQ":"纳指三倍做空ETF","SDS":"两倍做空标普500ETF","SH":"标普500反向ETF",".IXIC":"NASDAQ Composite","SPXU":"三倍做空标普500ETF",".SPX":"S&P 500 Index","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","OEX":"标普100","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","BK4504":"桥水持仓","UPRO":"三倍做多标普500ETF","LU0058720904.USD":"联博国际健康护理基金A","SPY":"标普500ETF","QID":"纳指两倍做空ETF","CPI":"IQ Real Return ETF","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","TQQQ":"纳指三倍做多ETF","LU0122379950.USD":"贝莱德世界健康科学A2","BK4581":"高盛持仓","OEF":"标普100指数ETF-iShares"},"translate_title":"美国股市——道琼斯指数领涨，投资者等待利率线索","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CPI":1,"PPI":1,"US10Y.BOND":0.9,"US12M.BOND":0.9,"COMP":0.9,"US2Y.BOND":0.9,"US30Y.BOND":0.9,"US3Y.BOND":0.9,"MRK":0.9,"US5Y.BOND":0.9,"US6M.BOND":0.9,"US7Y.BOND":0.9,"SPY":0.66,".IXIC":0.66,"US912796CX52.BOND":0.6,"US912797FH58.BOND":0.6,"US912797FS14.BOND":0.6,"US912797GB79.BOND":0.6,"US912797GK78.BOND":0.6,"US912797GL51.BOND":0.6,"US912797GW17.BOND":0.6,"US912797HE00.BOND":0.6,"US912797HG57.BOND":0.6,"UPRO":0.6,"TQQQ":0.6,"US912797HH31.BOND":0.6,"SSO":0.6,"SQQQ":0.6,".SPX":0.6,"ESmain":0.6,"MNQmain":0.6,"NQmain":0.6,"IVV":0.6,"SPXU":0.6,"OEF":0.6,"OEX":0.6,"PSQ":0.6,"QID":0.6,"QLD":0.6,"QQQ":0.6,"SDS":0.6,"SH":0.6},"content_text":"* \n Merck up after US FDA approves therapy for rare lung condition \n * \n Trump's media firm extends gains after stellar debut \n * \n GameStop faces 'unsustainable' sales decline, shares slide \n * \n Indexes up: Dow 0.77%, S&P 0.46%, Nasdaq 0.22% \n (Updated at 2:26 p.m. ET/ 1826 GMT) \n By Chuck Mikolajczak \n NEW YORK, March 27 (Reuters) - The Dow was the best performing of the three major indexes on Wednesday, paced by gains in drugmaker Merck, while as investors looked towards the next piece of inflation data and Federal Reserve policymaker commentary for insight on the rate path. \n Merck & Co advanced 4.77% as the biggest boost and percentage gained on the Dow after the U.S. Food and Drug Administration approved its therapy for adults suffering from a rare lung condition. \n The blue-chip Dow sits roughly 1% away from breaking the 40,000 level for the first time. \n Gains on the tech-heavy Nasdaq were capped by AI giant Nvidia which lost 2.59% and was on track for its second straight decline. Shares were still up more than 80% on the year, however. \n Recent data that showed hotter than expected inflation in the form of consumer prices (CPI) and producer prices (PPI) failed to markedly disrupt market expectations for a rate cut of at least 25 basis points (bps) from the Federal Reserve in June. \n The Fed kept its projections for three rate cuts this year intact at its policy meeting last week, which Fed officials have largely stood by this week in comments. \n The Personal Consumption Expenditures Price Index (PCE), the Fed's preferred inflation gauge, is due on Good Friday, when the U.S. stock market will be closed. \n \"We're living in between the space of those data-heavy bookends, and the markets are largely behaving as we would expect them to in that void, which is we're seeing equities largely tread water, a little bit of weakness which I would probably chalk up more so to just quarter-end rebalancing,\" said Craig Fehr, head of investment strategy at Edward Jones in St. Louis. \n \"But we have the markets that are keenly anchored on the big data points, which is inflation, Fed decisions, and the labor market.\" \n Later in the day, Fed Board Governor Christopher Waller is expected to speak at the Economic Club of New York later in the day. \n The Dow Jones Industrial Average rose 307.35 points, or 0.77%, to 39,584.13, the S&P 500 gained 23.92 points, or 0.46%, to 5,227.50 and the Nasdaq Composite gained 35.50 points, or 0.22%, to 16,351.19. \n All three major U.S. stock indexes were poised for quarterly gains, with the S&P on track for its biggest first quarter percentage gain since 2019. \n Traders see a 70.4% chance the Fed will begin its easing cycle in June, according to the CME FedWatch Tool. \n Nine of the 11 major S&P 500 sectors were trading higher, with rate sensitive utilities and real estate leading the best performers as bond yields eased. \n Among individual stocks, Trump Media & Technology Group jumped 14.16%, a day after its stellar Nasdaq debut. \n GameStop plunged 14.77% after the videogame retailer reported lower fourth-quarter revenue and said it had cut an unspecified number of jobs to reduce costs. \n Advancing issues outnumbered decliners by a 3.43-to-1 ratio on the NYSE while advancing issues outnumbered decliners by about a 2.43-to-1 ratio on the Nasdaq. \n The S&P 500 posted 43 new 52-week highs and no new lows while the Nasdaq recorded 131 new highs and 72 new lows. (Reporting by Chuck Mikolajczak; Editing by Aurora Ellis)","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2422879940"}